The global contraceptive devices market is anticipated to grow at a significant CAGR during the forecast period (2021-2027). The major factors that are driving the growth of the global contraceptive devices market during the forecast period include the increased use of contraceptive devices, due to an increasing number of unwanted pregnancies and the increasing awareness about sexually transmitted diseases (STDs). Moreover, initiatives by governments to raise awareness regarding contraceptives and family planning is also expected to fuel the growth of the global contraceptive devices market during the forecast period.
Contraceptive devices are considered as barriers that prevent pregnancy by physically preventing sperm from entering the uterus. Contraception is more commonly known as fertility, and birth control is described as the method used to avoid pregnancy. These devices include male condoms, female condoms, cervical caps, diaphragms, and contraceptive sponges with spermicide. Furthermore, the global contraceptive devices market analysis includes some of the key market players such as Allergan PLC., Bayer Healthcare, Cooper Surgical Inc., Mylan Laboratories, and Pfizer Inc., among others.
Market Coverage
Competitive Landscape: Allergan PLC., Bayer Healthcare, Cooper Surgical Inc., Mylan Laboratories, and Pfizer Inc., among others.
Key questions addressed by the report
o Recovery Timeline
o Deviation from pre-COVID forecast
o Most affected region and segment
Global Contraceptive Devices Market by Segment
By Type
• Condoms
• Diaphragms
• Cervical Caps
• Sponges
• Vaginal Rings
• Intra-Uterine Device (IUD),
• Other Types
By Gender
• Male
• Female
Global Contraceptives Device Market by Region
North America
Europe
Asia-Pacific
Rest of the World